| The treatment of children with unilateral Wilms' tumor |
| DM Green, NE Breslow, and GJ D'Angio |
|
JCO Jun 1 1993: 1009–1010.
[PDF]
|
 |
| The physician as the patient's advocate. American Society of Clinical Oncology Committee of Patient Advocacy |
|
|
JCO Jun 1 1993: 1011–1013.
[PDF]
|
|
|
Results of the Sixth International Society of Pediatric Oncology Wilms' Tumor Trial and Study: a risk-adapted therapeutic approach in Wilms' tumor |
| |
MF Tournade, C Com-Nougue, PA Voute, J Lemerle, J de Kraker, JF Delemarre, M Burgers, JL Habrand, CG Moorman, and D Burger |
| |
JCO Jun 1 1993: 1014–1023.
[Abstract]
[PDF]
|
|
|
Long-term follow-up of patients treated with COMP or LSA2L2 therapy for childhood non-Hodgkin's lymphoma: a report of CCG-551 from the Childrens Cancer Group |
| |
JR Anderson, RD Jenkin, JF Wilson, CR Kjeldsberg, R Sposto, RR Chilcote, PF Coccia, PR Exelby, S Siegel, and AT Meadows |
| |
JCO Jun 1 1993: 1024–1032.
[Abstract]
[PDF]
|
|
|
Cardiac dysfunction following spinal irradiation during childhood |
| |
RI Jakacki, JW Goldwein, RL Larsen, G Barber, and JH Silber |
| |
JCO Jun 1 1993: 1033–1038.
[Abstract]
[PDF]
|
|
|
Secondary acute myeloid leukemia in children previously treated with alkylating agents, intercalating topoisomerase II inhibitors, and irradiation |
| |
C Sandoval, CH Pui, LC Bowman, D Heaton, CA Hurwitz, SC Raimondi, FG Behm, and DR Head |
| |
JCO Jun 1 1993: 1039–1045.
[Abstract]
[PDF]
|
|
|
Prospective comparative study of bone marrow transplantation and postremission chemotherapy for childhood acute myelogenous leukemia. The Associazione Italiana Ematologia ed Oncologia Pediatrica Cooperative Group |
| |
S Amadori, AM Testi, M Arico, A Comelli, M Giuliano, E Madon, G Masera, R Rondelli, L Zanesco, and F Mandelli |
| |
JCO Jun 1 1993: 1046–1054.
[Abstract]
[PDF]
|
|
|
Effect of prior interferon alfa therapy on the outcome of allogeneic bone marrow transplantation for chronic myelogenous leukemia |
| |
SA Giralt, HM Kantarjian, M Talpaz, MB Rios, A Del Giglio, BS Andersson, D Przepiorka, AB Deisseroth, and RE Champlin |
| |
JCO Jun 1 1993: 1055–1061.
[Abstract]
[PDF]
|
|
|
Accelerated hyperfractionated total-lymphoid irradiation, high-dose chemotherapy, and autologous bone marrow transplantation for refractory and relapsing patients with Hodgkin's disease |
| |
J Yahalom, SC Gulati, M Toia, P Maslak, EG McCarron, JP O'Brien, CS Portlock, DJ Straus, J Phillips, and Z Fuks |
| |
JCO Jun 1 1993: 1062–1070.
[Abstract]
[PDF]
|
|
|
Infusional cyclophosphamide, doxorubicin, and etoposide in relapsed and resistant non-Hodgkin's lymphoma: evidence for a schedule-dependent effect favoring infusional administration of chemotherapy |
| |
JA Sparano, PH Wiernik, A Leaf, and JP Dutcher |
| |
JCO Jun 1 1993: 1071–1079.
[Abstract]
[PDF]
|
|
|
Acute hypersensitivity reactions to etoposide in a VEPA regimen for Hodgkin's disease |
| |
MM Hudson, HJ Weinstein, SS Donaldson, C Greenwald, L Kun, NJ Tarbell, WA Humphrey, C Rupp, NM Marina, and J Wilimas |
| |
JCO Jun 1 1993: 1080–1084.
[Abstract]
[PDF]
|
|
|
Prognostic factors for treatment outcome in autotransplantation of intermediate-grade and high-grade non-Hodgkin's lymphoma with cyclophosphamide, carmustine, and etoposide |
| |
C Wheeler, M Strawderman, L Ayash, WH Churchill, BE Bierer, A Elias, DG Gilliland, K Antman, EC Guinan, and JP Eder |
| |
JCO Jun 1 1993: 1085–1091.
[Abstract]
[PDF]
|
|
|
Gallium scans in patients with mediastinal Hodgkin's disease treated with chemotherapy |
| |
DL Cooper, VJ Caride, M Zloty, J Germino, LR Farber, and PB Hoffer |
| |
JCO Jun 1 1993: 1092–1098.
[Abstract]
[PDF]
|
|
|
Parameters affecting the development of non-Hodgkin's lymphoma in patients with severe human immunodeficiency virus infection receiving antiretroviral therapy |
| |
JM Pluda, DJ Venzon, G Tosato, J Lietzau, K Wyvill, DL Nelson, ES Jaffe, JE Karp, S Broder, and R Yarchoan |
| |
JCO Jun 1 1993: 1099–1107.
[Abstract]
[PDF]
|
|
|
Prognostic role of serum beta 2-microglobulin in Hodgkin's disease |
| |
MA Dimopoulos, F Cabanillas, JJ Lee, F Swan, L Fuller, PK Allen, and FB Hagemeister |
| |
JCO Jun 1 1993: 1108–1111.
[Abstract]
[PDF]
|
|
|
Postoperative radiation therapy for high-risk colon carcinoma |
| |
CG Willett, CY Fung, DS Kaufman, J Efird, and PC Shellito |
| |
JCO Jun 1 1993: 1112–1117.
[Abstract]
[PDF]
|
|
|
Preoperative chemoradiation followed by transhiatal esophagectomy for carcinoma of the esophagus: final report |
| |
AA Forastiere, MB Orringer, C Perez-Tamayo, SG Urba, and M Zahurak |
| |
JCO Jun 1 1993: 1118–1123.
[Abstract]
[PDF]
|
|
|
A multicenter, randomized, double-blind, placebo-controlled, dose- titration study of oral pilocarpine for treatment of radiation-induced xerostomia in head and neck cancer patients |
| |
FG LeVeque, M Montgomery, D Potter, MB Zimmer, JW Rieke, BW Steiger, SC Gallagher, and CC Muscoplat |
| |
JCO Jun 1 1993: 1124–1131.
[Abstract]
[PDF]
|
|
|
High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer |
| |
WP Peters, M Ross, JJ Vredenburgh, B Meisenberg, LB Marks, E Winer, J Kurtzberg, RC Bast, Jr, R Jones, and E Shpall |
| |
JCO Jun 1 1993: 1132–1143.
[Abstract]
[PDF]
|
|
|
Rapid administration of multiple cycles of high-dose myelosuppressive chemotherapy in patients with metastatic breast cancer |
| |
J Crown, A Kritz, L Vahdat, L Reich, M Moore, N Hamilton, J Schneider, M Harrison, T Gilewski, and C Hudis |
| |
JCO Jun 1 1993: 1144–1149.
[Abstract]
[PDF]
|
|
|
Cell kinetics as a predictive factor in node-positive breast cancer treated with adjuvant hormone therapy |
| |
R Silvestrini, MG Daidone, M Mastore, G Di Fronzo, D Coradini, P Boracchi, P Squicciarini, B Salvadori, and U Veronesi |
| |
JCO Jun 1 1993: 1150–1155.
[Abstract]
[PDF]
|
|
|
Impact of cyclophosphamide on relationships between carboplatin exposure and response or toxicity when used in the treatment of advanced ovarian cancer |
| |
LM Reyno, MJ Egorin, RM Canetta, DI Jodrell, KD Swenerton, JL Pater, JN Burroughs, MJ Novak, and R Sridhara |
| |
JCO Jun 1 1993: 1156–1164.
[Abstract]
[PDF]
|
|
|
Alternating combination VCMP/VBAP chemotherapy versus melphalan/prednisone in the treatment of multiple myeloma: a randomized multicentric study of 487 patients |
| |
J Blade, JF San Miguel, A Alcala, J Maldonado, MA Sanz, J Garcia-Conde, MJ Moro, C Alonso, J Besalduch, and A Zubizarreta |
| |
JCO Jun 1 1993: 1165–1171.
[Abstract]
[PDF]
|
|
|
Node status has prognostic significance in the multimodality therapy of diffuse, malignant mesothelioma |
| |
DJ Sugarbaker, GM Strauss, TJ Lynch, W Richards, SJ Mentzer, TH Lee, JM Corson, and KH Antman |
| |
JCO Jun 1 1993: 1172–1178.
[Abstract]
[PDF]
|
|
|
Pharmacodynamics of prolonged oral etoposide in patients with advanced non-small-cell lung cancer |
| |
AA Miller, EA Tolley, HB Niell, JP Griffin, and AM Mauer |
| |
JCO Jun 1 1993: 1179–1188.
[Abstract]
[PDF]
|
|
|
Adherence to oral tamoxifen: a comparison of patient self-report, pill counts, and microelectronic monitoring |
| |
DM Waterhouse, KA Calzone, C Mele, and DE Brenner |
| |
JCO Jun 1 1993: 1189–1197.
[Abstract]
[PDF]
|
|
| Bowel complications with taxol therapy |
| V Seewaldt, JM Cain, BE Greer, H Tamimi, and DC Figge |
|
JCO Jun 1 1993: 1198a.
[PDF]
|
|
| Cancer pain or "total" cancer pain? |
| A Khojasteh, J Chambers, S Khojasteh, and M Keeney |
|
JCO Jun 1 1993: 1198b.
[PDF]
|
|
